“Trial and error” remains the basis for the care of people who have recently been diagnosed with psychosis, and “poor outcomes are common,” say a team of researchers at the University of California, ...

Alfredo Bellon, MD, PhD, shares how he treats patients who have psychosis from drug use, a psychiatric disorder, or both.

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford ...

A pioneering therapy targeting distressing and disturbing mental images for people with psychosis could lead to a transformative intervention for a condition estimated to cost England almost £12 ...

MADRID — Recent research on the progression and treatment of psychosis is prompting some experts to ask: Are substance-induced psychosis (SIP) and primary psychosis fundamentally different? And if ...

MANCHESTER, UNITED KINGDOM, March 10, 2026 /EINPresswire.com/ — Monument Therapeutics, a stratified medicine company, today announced that the first patient has ...

Teva aims to expand its schizophrenia portfolio after the EMA accepts its filing for olanzapine long-acting injectable ...